SCYNEXIS, Inc. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
SCYNEXIS, Inc. (SCYX) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $164.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2018-11-13
- 2018-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $164.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $353.00K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $510.00K.
- 2017-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $78.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2018-09-30 | $164.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $353.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $510.00K 10-Q · filed 2018-05-08 |
| 2017-09-30 | $78.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $155.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $231.00K 10-Q · filed 2017-05-08 |
| 2016-09-30 | $76.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $151.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $224.00K 10-Q · filed 2016-05-09 |
| 2015-09-30 | $97.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $550.00K 10-Q · filed 2015-08-19 |
| 2015-03-31 | $826.00K 8-K · filed 2015-10-30 |
| 2014-09-30 | $264.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $530.00K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $797.00K 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |